The latter are associated with a substantial risk to transform to AML, and include, among other, mutations in FLT3, RUNX1, WT1, NPM1, NRAS, and TP53 [30,31,32,33,34,35,77]. Here, FLT3 is linked to acute myeloid leukemia.